Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
COVID-19 and cancer researchBritish Journal of Cancer, 2020-09, Vol.123 (5), p.689-690 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.springernature.com/gp/researchers/campaigns/coronavirus ;Cancer Research UK 2020. ;Cancer Research UK 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-0960-1 ;PMID: 32591747Digital Resources/Online E-Resources |
|
2 |
Material Type: Article
|
Redefining cancer research for therapeutic breakthroughsBritish journal of cancer, 2024-04, Vol.130 (7), p.1078-1082 [Peer Reviewed Journal]2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-024-02634-6 ;PMID: 38424166Full text available |
|
3 |
Material Type: Article
|
P124 High throughput multiplex immunoassays stratify patients according to symptom burden across the Lupus-Sjögren’s spectrumLupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A129-A130 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2024-el.178Full text available |
|
4 |
Material Type: Article
|
At the onset of an infodemic: Geographic and disciplinary boundaries in researching problematic COVID-19 informationFirst Monday, 2022-07, Vol.27 (7) [Peer Reviewed Journal]Copyright University of Illinois at Chicago Library Jul 4, 2022 ;ISSN: 1396-0466 ;EISSN: 1396-0466 ;DOI: 10.5210/fm.v27i7.12557Full text available |
|
5 |
Material Type: Article
|
Radiation Reveal: Moving from research engagement to involvementBritish journal of cancer, 2024-06, Vol.130 (10), p.1593-1598 [Peer Reviewed Journal]2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-024-02648-0 ;PMID: 38615107Full text available |
|
6 |
Material Type: Article
|
Collegiate Athletic Trainers' Experiences Implementing Return to Sports Policies and Procedures During COVID-19: A Qualitative Research StudyJournal of athletic training, 2022-06 [Peer Reviewed Journal]Copyright National Athletic Trainers Association Jun 2022 ;ISSN: 1062-6050 ;EISSN: 1938-162X ;DOI: 10.4085/1062-6050-0004.22Full text available |
|
7 |
Material Type: Article
|
First person – John (Eddie) Edmund La MarcaDisease models & mechanisms, 2023-03, Vol.16 (3) [Peer Reviewed Journal]2023. This work is licensed under https://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023. Published by The Company of Biologists Ltd 2023 ;ISSN: 1754-8403 ;EISSN: 1754-8411 ;DOI: 10.1242/dmm.050179Full text available |
|
8 |
Material Type: Article
|
A peek into cancer-associated fibroblasts: origins, functions and translational impactDisease models & mechanisms, 2018-04, Vol.11 (4) [Peer Reviewed Journal]2018. Published by The Company of Biologists Ltd. ;2018. This work is licensed under http://creativecommons.org/licenses/by/3.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018. Published by The Company of Biologists Ltd 2018 ;ISSN: 1754-8403 ;EISSN: 1754-8411 ;DOI: 10.1242/dmm.029447 ;PMID: 29686035Full text available |
|
9 |
Material Type: Article
|
Let the question determine the methods: descriptive epidemiology done rightBritish journal of cancer, 2020-10, Vol.123 (9), p.1351-1352 [Peer Reviewed Journal]Cancer Research UK 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-1019-z ;PMID: 32814836Full text available |
|
10 |
Material Type: Article
|
Animal models for bone tissue engineering and modelling diseaseDisease models & mechanisms, 2018-04, Vol.11 (4) [Peer Reviewed Journal]2018. Published by The Company of Biologists Ltd. ;2018. This work is licensed under http://creativecommons.org/licenses/by/3.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018. Published by The Company of Biologists Ltd 2018 ;ISSN: 1754-8403 ;EISSN: 1754-8411 ;DOI: 10.1242/dmm.033084 ;PMID: 29685995Full text available |
|
11 |
Material Type: Article
|
Living with Multiple Sclerosis: A Phenomenological Study of Worries, Concern and Psychological Problems in Iranian Patients with MSQualitative report, 2020-08, Vol.25 (8), p.COV8 [Peer Reviewed Journal]COPYRIGHT 2020 Nova Southeastern University, Inc. ;ISSN: 1052-0147 ;EISSN: 2160-3715 ;DOI: 10.46743/2160-3715/2020.3630Full text available |
|
12 |
Material Type: Article
|
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLCBritish journal of cancer, 2018-03, Vol.118 (6), p.820-824 [Peer Reviewed Journal]Copyright Nature Publishing Group Mar 20, 2018 ;Copyright © 2018 Cancer Research UK 2018 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2018.9 ;PMID: 29509748Full text available |
|
13 |
Material Type: Article
|
Nonrandomised controlled trial in recurrent glioblastoma patients: the promise of autologous tumour lysate-loaded dendritic cell vaccinationBritish journal of cancer, 2023-10, Vol.129 (6), p.895-896 [Peer Reviewed Journal]2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-023-02194-1 ;PMID: 36792723Full text available |
|
14 |
Material Type: Article
|
The untapped potential of ascites in ovarian cancer research and treatmentBritish journal of cancer, 2020-07, Vol.123 (1), p.9-16 [Peer Reviewed Journal]The Author(s), under exclusive licence to Cancer Research UK 2020. ;The Author(s), under exclusive licence to Cancer Research UK 2020 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-020-0875-x ;PMID: 32382112Full text available |
|
15 |
Material Type: Article
|
Animals, quality and the pursuit of relevanceDisease models & mechanisms, 2022-10, Vol.15 (10) [Peer Reviewed Journal]2022. This work is licensed under https://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1754-8403 ;EISSN: 1754-8411 ;DOI: 10.1242/dmm.049775Full text available |
|
16 |
Material Type: Article
|
How inclusive are cell lines in preclinical engineered cancer models?Disease models & mechanisms, 2022-05, Vol.15 (5) [Peer Reviewed Journal]2022. Published by The Company of Biologists Ltd. ;2022. This work is licensed under https://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022. Published by The Company of Biologists Ltd 2022 ;ISSN: 1754-8403 ;EISSN: 1754-8411 ;DOI: 10.1242/dmm.049520 ;PMID: 35642685Full text available |
|
17 |
Material Type: Article
|
Different operationalizations of the 2018 WCRF/AICR cancer prevention recommendations and risk of cancerBritish journal of cancer, 2023-10, Vol.129 (6), p.982-992 [Peer Reviewed Journal]2023. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-023-02314-x ;PMID: 37500788Full text available |
|
18 |
Material Type: Article
|
REPRESENT recommendations: improving inclusion and trust in cancer early detection researchBritish journal of cancer, 2023-10, Vol.129 (8), p.1195-1208 [Peer Reviewed Journal]The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-023-02414-8 ;PMID: 37689805Full text available |
|
19 |
Material Type: Article
|
Selected Abstracts from the 2018 NCRI Cancer Conference of National Cancer Research InstituteBritish journal of cancer, 2018-11, Vol.119 (Suppl 1), p.1-49 [Peer Reviewed Journal]2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Cancer Research UK 2018 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-018-0299-z ;PMID: 30405205Full text available |
|
20 |
Material Type: Article
|
Reporting guidelines for oncology research: helping to maximise the impact of your researchBritish journal of cancer, 2018-03, Vol.118 (5), p.619-628 [Peer Reviewed Journal]Copyright Nature Publishing Group Mar 6, 2018 ;Copyright © 2018 The Author(s) 2018 The Author(s) ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2017.407 ;PMID: 29471308Full text available |